TCL Archive ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market September 26, 1997
TCL Archive Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted September 6, 1974
TCL Archive Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers January 29, 1993
TCL Archive Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia July 26, 2002